Uricase Therapy
Uricase Therapy is a therapeutic enzyme treatment that catalyzes the oxidation of uric acid into the more soluble compound allantoin, thereby reducing serum urate levels in patients with refractory gout or hyperuricemia.
79
Publications
5.2K
Citations
444
Authors
145
Institutions
Publications per year
2017–2026
31
Parents
79
Nancy J. Ganson, Susan J. Kelly, Edna Scarlett et al. · Arthritis Research & Therapy · 2005 · 343 citations · Full text
Hyperuricemia Causes Glomerular Hypertrophy in the Rat
Takahiko Nakagawa, Marilda Mazzali, Duk‐Hee Kang et al. · American Journal of Nephrology · 2002 · 271 citations
Medicine, Nephrology, Pharmacology +12
Peter E. Lipsky, Leonard H. Calabrese, Arthur Kavanaugh et al. · Arthritis Research & Therapy · 2014 · 261 citations · Full text
1–5 of 79
444
6
h-index
The University of Texas Southwestern Medical Center, United States
5 publications · 891 citations
5
h-index
5
h-index
4
h-index
4
h-index
1–5 of 444
145
Chongqing Medical University
Chongqing, China
9 h-index
58 publications
2.5K citations
Duke Medical Center
Durham, United States
6 h-index
10 publications
2.9K citations
University of California San Diego
San Diego, United States
6 h-index
9 publications
601 citations
Duke University
Durham, United States
6 h-index
14 publications
2K citations
Army Medical University
Chongqing, China
4 h-index
5 publications
168 citations
Selecta Biosciences (United States)
Watertown, United States
4 h-index
20 publications
582 citations
Altoona Center for Clinical Research
Duncansville, United States
4 h-index
4 publications
112 citations
Massachusetts General Hospital
Boston, United States
4 h-index
12 publications
479 citations
1–8 of 145
Repository · 5 publications · 165 citations
5
h-index
ARD · 3 publications · 56 citations
3
h-index
3 publications · 129 citations
3
h-index
3 publications · 69 citations
3
h-index
3 publications · 653 citations
3
h-index
1–5